Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 100

1.

Development of novel therapy of schizophrenia in children and adolescents.

Klein C, Bespalov A.

Expert Opin Investig Drugs. 2014 Nov;23(11):1531-40. doi: 10.1517/13543784.2014.933806. Epub 2014 Jun 27.

PMID:
24970455
[PubMed - in process]
2.

Body weight and metabolic adverse effects of asenapine, iloperidone, lurasidone and paliperidone in the treatment of schizophrenia and bipolar disorder: a systematic review and exploratory meta-analysis.

De Hert M, Yu W, Detraux J, Sweers K, van Winkel R, Correll CU.

CNS Drugs. 2012 Sep 1;26(9):733-59. doi: 10.2165/11634500-000000000-00000. Review.

PMID:
22900950
[PubMed - indexed for MEDLINE]
3.

Drug Class Review: Atypical Antipsychotic Drugs: Final Update 3 Report [Internet].

McDonagh M, Peterson K, Carson S, Fu R, Thakurta S.

Portland (OR): Oregon Health & Science University; 2010 Jul.

4.

Asenapine, blonanserin, iloperidone, lurasidone, and sertindole: distinctive clinical characteristics of 5 novel atypical antipsychotics.

Wang SM, Han C, Lee SJ, Patkar AA, Masand PS, Pae CU.

Clin Neuropharmacol. 2013 Nov-Dec;36(6):223-38. doi: 10.1097/WNF.0b013e3182aa38c4. Review.

PMID:
24201235
[PubMed - indexed for MEDLINE]
5.

Iloperidone, asenapine and lurasidone: a primer on their current status.

Tarazi FI, Stahl SM.

Expert Opin Pharmacother. 2012 Sep;13(13):1911-22. doi: 10.1517/14656566.2012.712114. Epub 2012 Jul 31. Review.

PMID:
22849428
[PubMed - indexed for MEDLINE]
6.

[Metabolic side effects of risperidone in early onset schizophrenia].

Goeb JL, Marco S, Duhamel A, Kechid G, Bordet R, Thomas P, Delion P, Jardri R.

Encephale. 2010 Jun;36(3):242-52. doi: 10.1016/j.encep.2009.10.008. Epub 2009 Dec 1. French.

PMID:
20620267
[PubMed - indexed for MEDLINE]
7.

Atypical antipsychotics for psychosis in adolescents.

Kumar A, Datta SS, Wright SD, Furtado VA, Russell PS.

Cochrane Database Syst Rev. 2013 Oct 15;10:CD009582. doi: 10.1002/14651858.CD009582.pub2. Review.

PMID:
24129841
[PubMed - indexed for MEDLINE]
8.

[Antipsychotics in bipolar disorders].

Vacheron-Trystram MN, Braitman A, Cheref S, Auffray L.

Encephale. 2004 Sep-Oct;30(5):417-24. Review. French.

PMID:
15627046
[PubMed - indexed for MEDLINE]
9.

Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis.

Leucht S, Cipriani A, Spineli L, Mavridis D, Orey D, Richter F, Samara M, Barbui C, Engel RR, Geddes JR, Kissling W, Stapf MP, Lässig B, Salanti G, Davis JM.

Lancet. 2013 Sep 14;382(9896):951-62. doi: 10.1016/S0140-6736(13)60733-3. Epub 2013 Jun 27. Review. Erratum in: Lancet. 2013 Sep 14;382(9896):940.

PMID:
23810019
[PubMed - indexed for MEDLINE]
10.

Summary of the comparative effectiveness review on off-label use of atypical antipsychotics.

Maher AR, Theodore G.

J Manag Care Pharm. 2012 Jun;18(5 Suppl B):S1-20. Review.

PMID:
22784311
[PubMed - indexed for MEDLINE]
Free Article
11.

A review of the pharmacology, efficacy and tolerability of recently approved and upcoming oral antipsychotics: an evidence-based medicine approach.

Citrome L.

CNS Drugs. 2013 Nov;27(11):879-911. doi: 10.1007/s40263-013-0105-7. Review.

PMID:
24062193
[PubMed - indexed for MEDLINE]
12.

[Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].

Llorca PM, Miadi-Fargier H, Lançon C, Jasso Mosqueda G, Casadebaig F, Philippe A, Guillon P, Mehnert A, Omnès LF, Chicoye A, Durand-Zaleski I.

Encephale. 2005 Mar-Apr;31(2):235-46. Review. French.

PMID:
15959450
[PubMed - indexed for MEDLINE]
13.

Iloperidone, asenapine, and lurasidone: a brief overview of 3 new second-generation antipsychotics.

Citrome L.

Postgrad Med. 2011 Mar;123(2):153-62. doi: 10.3810/pgm.2011.03.2273. Review.

PMID:
21474903
[PubMed - indexed for MEDLINE]
14.

Safety of antipsychotic drugs: focus on therapeutic and adverse effects.

Werner FM, Coveñas R.

Expert Opin Drug Saf. 2014 Aug;13(8):1031-42. doi: 10.1517/14740338.2014.935761. Epub 2014 Jun 30.

PMID:
24975932
[PubMed - in process]
15.

A systematic review of meta-analyses of the efficacy of oral atypical antipsychotics for the treatment of adult patients with schizophrenia.

Citrome L.

Expert Opin Pharmacother. 2012 Aug;13(11):1545-73. doi: 10.1517/14656566.2011.626769. Epub 2011 Oct 17. Review.

PMID:
21999805
[PubMed - indexed for MEDLINE]
16.

Asenapine for schizophrenia and bipolar disorder: a review of the efficacy and safety profile for this newly approved sublingually absorbed second-generation antipsychotic.

Citrome L.

Int J Clin Pract. 2009 Dec;63(12):1762-84. doi: 10.1111/j.1742-1241.2009.02228.x. Epub 2009 Oct 14. Review.

PMID:
19840150
[PubMed - indexed for MEDLINE]
17.

World Psychiatric Association Pharmacopsychiatry Section statement on comparative effectiveness of antipsychotics in the treatment of schizophrenia.

Tandon R, Belmaker RH, Gattaz WF, Lopez-Ibor JJ Jr, Okasha A, Singh B, Stein DJ, Olie JP, Fleischhacker WW, Moeller HJ; Section of Pharmacopsychiatry, World Psychiatric Association.

Schizophr Res. 2008 Mar;100(1-3):20-38. doi: 10.1016/j.schres.2007.11.033. Epub 2008 Feb 19. Review.

PMID:
18243663
[PubMed - indexed for MEDLINE]
18.

The expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summary.

Kane JM, Leucht S, Carpenter D, Docherty JP; Expert Consensus Panel for Optimizing Pharmacologic Treatment of Psychotic Disorders.

J Clin Psychiatry. 2003;64 Suppl 12:5-19.

PMID:
14640142
[PubMed - indexed for MEDLINE]
19.

Amisulpride for schizophrenia.

Mota NE, Lima MS, Soares BG.

Cochrane Database Syst Rev. 2002;(2):CD001357. Review.

PMID:
12076408
[PubMed - indexed for MEDLINE]
20.

Newer atypical antipsychotic medication versus clozapine for schizophrenia.

Tuunainen A, Wahlbeck K, Gilbody SM.

Cochrane Database Syst Rev. 2000;(2):CD000966. Review.

PMID:
10796559
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk